Analyzing the dose distribution inside target volumes of cancer patients before radiation delivery and then selection of the biologically optimal dose distribution has been one of the crucial steps in recent treatment planning developments. Plan evaluation and optimization have been based on the physical dose distribution and dose-volume parameters for several decades. However, with the development of a. clinical radiobiology in both domains of tumor and normal tissue response to radiation, ii) existence of reliable clinical results, and b. emergence of new mathematical models in cancer biology and treatment, radiation scientists have been motivated to calculate tumor control probability (TCP) and normal tissue complication probability (NTCP) for modern complex clinical treatment plans. The prediction of clinical outcome in terms of TCP in radiation therapy and its development have been an interesting subject of investigations for several decades. Additionally, this process has provided new information on radiotherapy consequences such as increased local control rates and lower complications rates. It also has helped treatment teams to choose optimum plans for individual patients. In this overview, we will look into some of these studies and give emphasis on potential benefits of TCP/NTCP calculations in different areas of radiation therapy such as plan evaluation, and the uncertainties associated with dose delivery.
Keywords: Radiation therapy; Treatment planning; Radiobiological modelling;Tumor control probability; Normal tissue complication probability
An Overview on the Clinical Application of Radiobiological Modeling in Radiation Therapy of Cancer 2/7Copyright: ©2017 Mesbahi et al.The β i parameter denotes the repairable part of radiation damage which varies over the population of patients. Also i g shows the fraction of patients having as their radiosensitivity [4].There are several models for NTCP calculations using DVH, dosimetric data of each patient. [4] One of the most applied models is the Lyman-Kutcher-Burman (LKB) model [1]. The NTCP calculation in the LKB model is defined as:Where TD 50 (v) is the tolerance dose for a 50% complication probability caused by uniform irradiation to volume v, and where n is the volume exponent and m is a parameter that is inversely related to the steepness of the dose-response curve.The increasing number of publications on radiobiological modeling implies its progressive utilization in current clinical practice as well as in silico (computer) modelling research. Although, the main purpose of TCP/NTCP calculations has been to provide a surrogate tool for plan comparisons and optimum plan selection for a given treatment, there are many other investigations that have employed this approach to quantize the radiobiological consequences for different available modalities, and geometric errors, as well as comparing novel techniques for radiation therapy [2,[5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24]. Moreover, several studies have ut...